Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Dual/triple agonist Mar 21 | 2019OPKO Oxyntomodulin Ph2 Data; Is It Commercially Viable?Purchase Blast$599
Posted in: Dual/triple agonist Mar 21 | 2019New Lilly Tirzepatide vs. Tresiba Ph3 Pivotal Study (SURPASS-3)Purchase Blast$599
Posted in: GLP-1RA Mar 20 | 2019Thoughts on Oral Sema and Ozempic Filings; 3 NDAs to De-risk Regulatory UncertaintyPurchase Blast$599
Posted in: GLP-1RA Mar 18 | 2019Novo-Teva Generic Victoza Settled; Launch Date Rationale UnclearPurchase Blast$599
Posted in: Bolus Insulin Mar 15 | 2019Potential Sanofi Bs-Aspart US Regulatory Strategy; New Interchangeability TrialPurchase Blast$599
Posted in: SGLT2i Mar 13 | 2019Lexicon Quiet on Sota T1DM Review; Q4 '18 Earnings UpdatePurchase Blast$599
Posted in: Glucose Monitoring Mar 12 | 2019New Eversense Bridge Program; Senseonics Q4 '18 Earnings UpdatePurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Other Mar 12 | 2019Adocia Q4 '18 Earnings Update; No Call ConductedPurchase Blast$599
Posted in: Other Mar 12 | 2019Zafgen Q4 '18 Earnings Update; ZGN-1258 Discontinued in PWSPurchase Blast$599
Posted in: DPP-IVi, Dual/triple agonist, GLP-1RA, Other, SGLT2i Mar 11 | 2019New Head of AZ CVRMPurchase Blast$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Mar 08 | 2019Thoughts on Potential Livongo IPOPurchase Blast$599
Posted in: Glucose Monitoring Mar 07 | 2019Dexcom Loses Appeals Court Bid For AgaMatrix LawsuitPurchase Blast$599
Posted in: Basal Insulin Mar 06 | 2019Thoughts on Biocon Form 483 Observations and Impact to Semglee US LaunchPurchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Mar 05 | 2019New Glooko Business Model; Glooko Mobile App to be Given Away for FreePurchase Blast